News Releases Month Year Su Mo Tu We Th Fr Sa 25 26 27 28 29 30 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 1 2 3 4 5 Cancel OK Month Year Su Mo Tu We Th Fr Sa 25 26 27 28 29 30 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 1 2 3 4 5 Cancel OK Investor Alerts Year All Years 2022 2021 Keywords Go Advanced Search Search Search Headlines Only From To Asset Types Photos Video Audio Documents Events Standard 11.10.2022 Nuvalent Reviews Corporate and Pipeline Achievements and Reports Third Quarter 2022 Financial Results Read More > 11.03.2022 Nuvalent Announces Closing of Upsized Public Offering of Common Stock Read More > 10.31.2022 Nuvalent Announces Pricing of Public Offering of Common Stock Read More > 10.31.2022 Nuvalent Announces Public Offering of Common Stock Read More > 10.28.2022 Nuvalent Reports Preliminary Phase 1 Clinical Data from ARROS-1 Trial that Support Best-In-Class Potential of NVL-520 for Patients with ROS1-Positive NSCLC Read More > Show 5102550100 per page«12345678»
